News
Pfizer's 7.45% dividend yield can't offset weak growth, declining EPS, and patent risks. Read more on PFE and why analysts ...
Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands ...
Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...
21h
Zacks Investment Research on MSNPFE vs. LLY: Which Stock Is the Better Value Option?Investors interested in stocks from the Large Cap Pharmaceuticals sector have probably already heard of Pfizer (PFE) and Eli Lilly (LLY). But which of these two companies is the best option for those ...
Income investors have liked Pfizer (NYSE: PFE) for years. However, the big drugmaker's exceptionally juicy dividend these ...
The executive order that Donald Trump has signed over the last 24 hours could have a significant effect on pharmaceutical ...
The company disclosed revenue of $13.7 billion and adjusted earnings of $0.92 per share, compared to consensus estimates of $14.1 billion and $0.68, respectively.
Current polls show former PM Andrej Babiš and his right-wing populist ANO movement leading with 30.7% support.
Insider Monkey on MSN9d
Is Pfizer Inc. (PFE) The Most Profitable Cheap Stock to Buy Now?We recently compiled a list of the 10 Most Profitable Cheap Stocks to Buy Now. In this article, we are going to take a look ...
We recently published a list of 13 Stock Predictions That Jim Cramer Got Completely Wrong. In this article, we are going to ...
NEW YORK, April 29, 2025--Pfizer Inc. (NYSE: PFE) reported financial results for the first quarter of 2025 and reaffirmed its 2025 financial guidance(1). NEW YORK, April 26, 2025--Pfizer Inc ...
Pfizer (PFE) stock slips after the company's lower than expected Q1 2025 revenue and the firm seeks acquisitions to boost its obesity pipeline. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results